Toggle navigation
Goals &
Objectives
Distinguished
Faculty
Education &
Resources
Contact
Us
Toggle navigation
Goals & Objectives
Distinguished Faculty
Education & Resources▼
CME Programs
Find a Clinician
SpeakerReady
Polling Questions
Conference Calendar
Refer a Colleague
Literature
Resources
Contact
Polling Questions
< All Questions
According to the webcast:
with James G. Pfaus, PhD, IF
The melanocortin agonist bremelanotide is believed to increase sexual desire in women by which of the following mechanisms:
Inhibition of serotonin release in the prefrontal cortex
Activation of dopamine release in the medial preoptic area
Activation of norepinephrine release in the nucleus accumbens
Inhibition of progesterone release from the ovaries
Your answers are confidential and will be used for educational purposes only.
Submit